Autopsy report · NCT02357719

Effectiveness of VistaO2 FLUX Device in Screening of Sleep Apnea/Hypopnea Syndrome

“Lack of inclusion”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 2 years 3 months before it stopped.
• 96 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Sponsor type

University, hospital or other

Conditions

Sleep Apnea Syndromes

Interventions

VistaO2 FLUX device

Participants

96

Sites

2

Countries

France

Trials that died the same way

• Development of a Predictive Score for Local Complications of Femoral Bifurcation Surgery
  “lack of inclusions” (97% match in meaning)
• Pronostic Value of Endothelial Dysfunction in Heart Failure
  “Not enough inclusions” (85% match in meaning)
• Transfusion Effects in Myelodysplastic Patients: Limiting Exposure
  “Too few inclusions” (82% match in meaning)
• Bedside Therapeutic Monitoring of β-Lactam Levels in Newborns, Children and Adolescents Admitted to Intensive Care.
  “insufficient inclusions” (81% match in meaning)
• Effects of Early Musical Intervention on Prevalence and Severity of Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury
  “inclusion difficulties” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.